• Go to navigation
  • Go to content
AZ Brixham Laboratories

You are here

  • Home
  • Services to Industry
  • Biocidal Products
  • Biocidal Product?

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • News Archive
  • Introduction to Brixham Environmental Laboratory
  • Services to Industry
    • Industrial Chemicals (REACH)
    • Human Pharmaceuticals
    • Plant Protection
    • Veterinary Medicines
    • Biocidal Products
      • Testing requirements
      • Implementation of the Directive
      • Biocidal Product?
      • What is a Biocidal active?
  • Laboratory Capabilities
  • Innovative Environmental Science & Technologies
  • Useful Links
  • Free Resources
  • Find us
  • Contact
  • Download a brochure
  • Study Information Request
  • Sitemap
  • A-Z Index
  • REACH Seminar Presentations now available for viewing
  • REACH Testing Alliance
  • SETAC posters for downloading

What is a Biocidal Product?

Coast

Coast

A Biocidal Product contains a preparation of one or more active substances, in the form in which it is supplied to the user.

Borderline-cases

Since the definitions are rather complex, many border-line cases have arisen. These have been discussed within an expert group of all Member States and the Commission, with a Manual of Decisions being published based on these meetings.

All new active substances (those placed on the market after 14 May 2000) are authorised as described in the Directive. Existing active substnaces (those place on the market before 14 May 2000) will contine to be marketed if identified or notified by 28th March 2002. The existing active substances will be assessed under a 10-year review program. The  European Chemicals Bureau (ECB)  has produced a list of existing active substances via the ECB website.

  • Advanced search

Quick links

  • AstraZeneca International
  • REACH Testing Consortium
  • News from Chemical Watch
  • Contact Us for REACH Testing
  • What our customers have to say about us

Page tools

  • Print
  • Bookmark this page
AstraZeneca

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2009